Abbott Healthcare Products B.V.

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes

Phase 2

Completed

Conditions: Patients With Type 2 Diabetes

Interventions: Drug: Fenofibrate/CoQ10

First Posted Date: 2008-06-23

Last Posted Date: 2008-06-25

Lead Sponsor: Solvay Pharmaceuticals

Target Recruit Count: 278

Registration Number: NCT00703482

Locations: 🇦🇺
Site 003, Nedlands, Australia
🇦🇺
Site 002, Fremantle, Australia
🇦🇺
Site 001, Perth, Australia

A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

Phase 2

Completed

Conditions: Patients With Metabolic Syndrome

Interventions: Drug: Fenofibrate /Metformin
Drug: Placebo

First Posted Date: 2008-06-23

Last Posted Date: 2008-06-25

Lead Sponsor: Solvay Pharmaceuticals

Target Recruit Count: 2288

Registration Number: NCT00703755

Locations: 🇨🇦
Site 007, Chicoutimi, Canada
🇨🇦
Site 010, St. John's, Canada
🇨🇦
Site 004, Hamilton, Canada

and more 98 locations

Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)

Phase 3

Completed

Conditions: Cystic Fibrosis
Pancreatic Exocrine Insufficiency

Interventions: Drug: Pancrelipase Delayed Release
Drug: Placebo Comparator

First Posted Date: 2008-06-05

Last Posted Date: 2010-06-02

Lead Sponsor: Solvay Pharmaceuticals

Target Recruit Count: 17

Registration Number: NCT00690820

Locations: 🇺🇸
Site 10, Oklahoma City, Oklahoma, United States
🇺🇸
Site 2, Iowa City, Iowa, United States
🇺🇸
Site 5, Louisville, Kentucky, United States

and more 7 locations

Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting

Phase 3

Completed

Conditions: Chemotherapy Induced Nausea and Vomiting

Interventions: Drug: dronabinol/ondansetron
Drug: placebo
Drug: dronabinol
Drug: ondansetron

First Posted Date: 2008-03-25

Last Posted Date: 2008-04-03

Lead Sponsor: Solvay Pharmaceuticals

Target Recruit Count: 64

Registration Number: NCT00642512

Locations: 🇺🇸
Site 943, Rancho Mirage, California, United States
🇺🇸
Site 922, Marietta, Georgia, United States
🇺🇸
Site 905, Southfield, Michigan, United States

and more 40 locations

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

Phase 2

Completed

Conditions: Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting
HIV Infections

Interventions: Drug: Placebo
Drug: Dronabinol

First Posted Date: 2008-03-25

Last Posted Date: 2008-04-02

Lead Sponsor: Solvay Pharmaceuticals

Target Recruit Count: 103

Registration Number: NCT00642499

Locations: 🇺🇸
Site 914, Chicago, Illinois, United States
🇺🇸
Site 929, Sarasota, Florida, United States
🇺🇸
Site 952, Tallahassee, Florida, United States

and more 33 locations

Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

Phase 2

Terminated

Conditions: Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

Interventions: Drug: Placebo
Drug: Recombinant Microbial Lipase SLV339

First Posted Date: 2008-03-06

Last Posted Date: 2009-08-06

Lead Sponsor: Solvay Pharmaceuticals

Target Recruit Count: 56

Registration Number: NCT00630279

Locations: 🇨🇿
Site 4205, Praha, Czech Republic
🇭🇺
Site 3606, Pecs, Hungary
🇵🇱
Site 4810, Gdansk, Poland

and more 47 locations

Effect of Omacor on Triglycerides in HIV Infected Subjects

Phase 4

Terminated

Conditions: Hyper-Triglyceridemia

Interventions: Drug: Omacor
Drug: Placebo

First Posted Date: 2008-01-23

Last Posted Date: 2009-03-30

Lead Sponsor: Solvay Pharmaceuticals

Target Recruit Count: 51

Registration Number: NCT00598910

Locations: 🇩🇪
Site 2, Bochum, Germany
🇬🇧
Site 5, London, United Kingdom
🇩🇪
Site 1, Hannover, Germany

and more 2 locations

Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years

Phase 1

Completed

Conditions: Healthy

Interventions: Biological: Seasonal cell-derived influenza vaccine
Biological: Placebo Comparator

First Posted Date: 2008-01-23

Last Posted Date: 2008-06-30

Lead Sponsor: Solvay Pharmaceuticals

Target Recruit Count: 120

Registration Number: NCT00599443

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Terminated

Conditions: Congestive Heart Failure

First Posted Date: 2007-12-05

Last Posted Date: 2008-04-22

Lead Sponsor: Solvay Pharmaceuticals

Target Recruit Count: 300

Registration Number: NCT00568009

Locations: 🇺🇸
Site 90, Miami, Florida, United States
🇦🇷
Site 11, Bahia Blanca, Argentina
🇦🇷
Site 6, Coronel Suarez, Argentina

and more 69 locations

Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine

Phase 1

Terminated

Conditions: Healthy Subjects

Interventions: Biological: S205 placebo
Biological: S205 10ugHA
Biological: S205 30ugHA
Biological: S205 10ugHA+500ugAlOH
Biological: S205 30ugHA+500ugAlOH
Biological: S205 10ugHA+1250ugAlOH
Biological: S205 30ugHA+1250ugAlOH

First Posted Date: 2007-11-21

Last Posted Date: 2008-10-27

Lead Sponsor: Solvay Pharmaceuticals

Target Recruit Count: 400

Registration Number: NCT00562237

Locations: 🇫🇮
Site 21, Helsinki, Finland
🇫🇮
Site 22, Tampere, Finland
🇫🇮
Site 23, Turku, Finland

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy